Articolo pubblicato su Rivista: [38605] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 641 a 660 di 38.605
Titolo Data di pubblicazione Autore(i) File
Phase III study of cabozantinib in previously treated metastatic castration-resistant prostate cancer: COMET-1 1-gen-2016 Smith, M; De Bono, J; Sternberg, C; Le Moulec, S; Oudard, S; De Giorgi, U; Krainer, M; Bergman, A; Hoelzer, W; De Wit, R; Bögemann, M; Saad, F; Cruciani, G; Thiery-Vuillemin, A; Feyerabend, S; Miller, K; Houédé, N; Hussain, S; Lam, E; Polikoff, J; Stenzl, A; Mainwaring, P; Ramies, D; Hessel, C; Weitzman, A; Fizazi, K.
Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer 1-gen-2016 Passardi, A; Scarpi, E; Cavanna, L; Dall'Agata, M; Tassinari, D; Leo, S; Bernardini, I; Gelsomino, F; Tamberi, S; Brandes, Aa; Tenti, E; Vespignani, R; Frassineti, Gl; Amadori, D; De Giorgi, U
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey 1-gen-2016 Diminutto, A; Basso, U; Maruzzo, M; Morelli, F; De Giorgi, U; Perin, A; Fraccon, Ap; Lo Re, G; Rizzi, A; Sava, T; Fornarini, G; Valcamonico, F; Zustovich, F; Massari, F; Zanardi, E; Roma, A; Zattoni, F; Zagonel, V
Radiofrequency ablation of liver malignancies: MRI for evaluation of response 1-gen-2004 Aliberti, C; Soriani, M; Tilli, M; Benea, G; De Giorgi, U; Fiorentini, G
Circulating tumor cells in newly diagnosed inflammatory breast cancer 1-gen-2015 Mego, M; Giordano, A; De Giorgi, U; Masuda, H; Hsu, L; Giuliano, M; Fouad, Tm; Dawood, S; Ueno, Nt; Valero, V; Andreopoulou, E; Alvarez, Rh; Woodward, Wa; Hortobagyi, Gn; Cristofanilli, M; Reuben, Jm
Methylation pattern analysis in prostate cancer tissue: Identification of biomarkers using an MS-MLPA approach 1-gen-2016 Gurioli, G; Salvi, S; Martignano, F; Foca, F; Gunelli, R; Costantini, M; Cicchetti, G; De Giorgi, U; Sbarba, Pd; Calistri, D; Casadio, V
68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer 1-gen-2018 Malaspina, Simona; De Giorgi, Ugo; Kemppainen, Jukka; Del Sole, Angelo; Paganelli, Giovanni
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 1-gen-2016 Marchetti, C; Ferrandina, G; Cormio, G; Gambino, A; Cecere, S; Lorusso, D; De Giorgi, U; Bogliolo, S; Fagotti, A; Mammoliti, S; Narducci, F; Bergamini, A; Scollo, P; Biglia, N; Breda, E; Tamberi, S; Marinaccio, M; Angioli, R; Salerno, L; Eusebi, Mc; Loizzi, V; Scambia, G; Panici, Pb.
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer 1-gen-2019 Conteduca, V; Jayaram, A; Romero-Laorden, N; Wetterskog, D; Salvi, S; Gurioli, G; Scarpi, E; Castro, E; Marin-Aguilera, M; Lolli, C; Schepisi, G; Maugeri, A; Wingate, A; Farolfi, A; Casadio, V; Medina, A; Puente, J; Vidal, Mjm; Morales-Barrera, R; Villa-Guzmán, Jc; Hernando, S; Rodriguez-Vida, A; González-Del-Alba, A; Mellado, B; Gonzalez-Billalabeitia, E; Olmos, D; Attard, G; De Giorgi, U
Salvage high-dose chemotherapy in patients with germ cell tumors: an Italian experience with 84 patients 1-gen-2002 Rosti, G; De Giorgi, U; Salvioni, R; Papiani, G; Sebastiani, L; Argnani, M; Monti, G; Ferrante, P; Pizzocaro, G; Marangolo, M.
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study 1-gen-2014 Escudier, B; Porta, C; Bono, P; Powles, T; Eisen, T; Sternberg, Cn; Gschwend, Je; De Giorgi, U; Parikh, O; Hawkins, R; Sevin, E; Négrier, S; Khan, S; Diaz, J; Redhu, S; Mehmud, F; Cella, D.
Neuroendocrine differentiation in prostate cancer: Current and emerging therapy strategies 1-gen-2014 Conteduca, V; Aieta, M; Amadori, D; De Giorgi, U
Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function 1-gen-2015 De Giorgi, U; Yuan, J; Moroni, M; Veronese, S; Sartore-Bianchi, A; Broggini, M; Rosti, G; Strebhardt, K; Ruffini, Pa
Hyperthermia and hypoxia: new developments in anticancer chemotherapy 1-gen-2001 Zaffaroni, N; Fiorentini, G; De Giorgi, U
PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancer 1-gen-2015 Burgio, Sl; Conteduca, V; Rudnas, B; Carrozza, F; Campadelli, E; Bianchi, E; Fabbri, P; Montanari, M; Carretta, E; Menna, C; De Giorgi, U
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. 1-gen-2010 International Prognostic Factors Study, Group; Lorch, A; Beyer, J; Bascoul-Mollevi, C; Kramar, A; Einhorn, Lh; Necchi, A; Massard, C; De Giorgi, U; Fléchon, A; Margolin, Ka; Lotz, Jp; Germa Lluch, Jr; Powles, T; Kollmannsberger, Ck.
Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience 1-gen-2005 De Giorgi, U; Demirer, T; Wandt, H; Taverna, C; Siegert, W; Bornhauser, M; Kozak, T; Papiani, G; Ballardini, M; Rosti, G
Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results 1-gen-2017 Matteucci, F; Mezzenga, E; Caroli, P; Di Iorio, V; Sarnelli, A; Celli, M; Fantini, L; Moretti, A; Galassi, R; De Giorgi, U; Paganelli, G
Immunotherapy for prostate cancer: where we are headed 1-gen-2017 Schepisi, G; Farolfi, A; Conteduca, V; Martignano, F; De Lisi, D; Ravaglia, G; Rossi, L; Menna, C; Bellia, Sr; Barone, D; Gunelli, R; De Giorgi, U
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer 1-gen-2012 De Giorgi, U; Mego, M; Scarpi, E; Giuliano, M; Giordano, A; Reuben, Jm; Valero, V; Ueno, Nt; Hortobagyi, Gn; Cristofanilli, M
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 641 a 660 di 38.605
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 03 Articolo su Rivista38605
Autore
  • SPAGNOLO, Stefania Antonia1590
  • GORINI, Edoardo1578
  • VENTURA, Andrea1508
  • PRIMAVERA, Margherita1313
  • CHIODINI, GABRIELE1056
  • GRAVILI, FRANCESCO GIUSEPPE648
  • GIGLI, Giuseppe468
  • CINGOLANI, Roberto438
  • DE GIORGI, UGO FEDERICO FRANCESCO437
  • LONGO, LUIGI388
Data di pubblicazione
  • In corso di stampa43
  • 2020 - 202710433
  • 2010 - 201913552
  • 2000 - 20098692
  • 1990 - 19993962
  • 1980 - 19891442
  • 1970 - 1979447
  • 1961 - 196934
Editore
  • Elsevier BV:PO Box 211, 1000 AE A...454
  • American Institute of Physics:2 H...272
  • Giuffre Editore Spa:via Busto Ars...128
  • Elsevier Science Limited:Oxford F...99
  • Congedo Editore Luogo pubbl. Gal...72
  • IOP Publishing Limited:Dirac Hous...71
  • Springer Verlag Germany:Tiergarte...71
  • Kluwer Academic Publishers:Journa...54
  • IEEE / Institute of Electrical an...47
  • Societa Editrice il Mulino Spa:St...43
Rivista
  • JOURNAL OF HIGH ENERGY PHYSICS481
  • THE EUROPEAN PHYSICAL JOURNAL. C,...393
  • PHYSICS LETTERS. SECTION B392
  • PHYSICAL REVIEW LETTERS211
  • APPLIED PHYSICS LETTERS186
  • NUCLEAR INSTRUMENTS AND METHODS I...185
  • THE ASTROPHYSICAL JOURNAL180
  • PHYSICAL REVIEW D, PARTICLES, FIE...156
  • PHYSICAL REVIEW D148
  • ITINERARI DI RICERCA STORICA140
Keyword
  • ATLAS1158
  • LHC1151
  • High Energy Physics1130
  • Humans376
  • Mediterranean Sea185
  • Italy177
  • Female144
  • Animals143
  • Male127
  • Hadron-Hadron Scattering122
Lingua
  • eng25985
  • ita9002
  • fre415
  • spa191
  • ger146
  • por94
  • lat51
  • grc47
  • rus43
  • chi13
Accesso al fulltext
  • no fulltext32279
  • open4081
  • restricted1185
  • reserved1012
  • partially open32
  • mixed10
  • embargoed6